Gyre Therapeutics Inc. (GYRE)
NASDAQ: GYRE
· Real-Time Price · USD
8.79
-0.47 (-5.08%)
At close: May 05, 2025, 3:59 PM
8.81
0.23%
After-hours: May 05, 2025, 04:01 PM EDT
-5.08% (1D)
| Bid | 8.68 |
| Market Cap | 824M |
| Revenue (ttm) | 105.76M |
| Net Income (ttm) | 15.96M |
| EPS (ttm) | 0.05 |
| PE Ratio (ttm) | 175.8 |
| Forward PE | 6.8 |
| Analyst | n/a |
| Ask | 9.26 |
| Volume | 100,682 |
| Avg. Volume (20D) | 150,368 |
| Open | 9.17 |
| Previous Close | 9.26 |
| Day's Range | 8.68 - 9.17 |
| 52-Week Range | 6.11 - 19.00 |
| Beta | 2.30 |
About GYRE
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. It offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under phase 3 studies for dermatomyositis and systemic sclerosis-associated interstitial lung disease, pneumoconiosis, and diabetic kidney dise...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 12, 2006
Employees 579
Stock Exchange NASDAQ
Ticker Symbol GYRE
Website https://www.gyretx.com
1 month ago
-30.21%
Gyre Therapeutics shares are trading lower. The co...
Unlock content with
Pro Subscription
5 months ago
-9.56%
Gyre Therapeutics shares are trading lower after the company reported a year-over-year decline in Q3 financial results.
